COMPASS Pathways Plc American Depository Shares (CMPS)
NASDAQ: CMPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CMPS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.14B
- EPS (TTM)
- -$2.34
- Dividend yield
- None
- 52-week range
- 4.88 – 15.87
- Day range
- 7.82 – 8.43
- Volume / Avg
- 6.09M / 3.09M
- Beta
- —
- Shares outstanding
- 141.71M
52-week range
CMPS stock today
COMPASS Pathways Plc American Depository Shares (CMPS) closed at $8.05 on Nov 20, down 6.94% (-$0.60), versus the S&P 500's 3.70% decline. Shares are 49.3% below their 52-week high of $15.87, set on Sep 9, 2026 and 65.0% above the 52-week low of $4.88, in the middle of the past year's range. CMPS is up 16.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 55.7%.
COMPASS Pathways Plc American Depository Shares has posted a net loss over the last twelve months (EPS of -$2.34), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About COMPASS Pathways Plc American Depository Shares
Company profileCOMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Kabir Kumar Nath M.A., M.B.A.
- Headquarters
- London
- Employees
- 156
- IPO year
- 2020
- Website
- compasspathways.com
Financial highlights
Full financialsCOMPASS Pathways Plc American Depository Shares reported a net loss of $287.9 million, compared with a loss of $155.1 million a year earlier. Diluted earnings per share came in at -$3.08.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Growth | — | — | — | — | — |
| Net income | $-287.86M | $-155.12M | $-118.46M | $-91.50M | $-71.74M |
| EPS (diluted) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 |
Analyst forecast
ForecastConsensus (16 analysts)
strong_buy
Avg. price target
$23.31+189.57%
- Strong buy 3
- Buy 12
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 3, 2026
- EPS actual vs est.
- $-0.31 vs $-0.39
- Surprise
- +20.51%
CMPS news
All CMPS news- Compass Pathways: 3 Key Takeaways for Long-Term InvestorsNasdaqCMPS, HEI.A
- COMPASS Pathways plc Reports Third Quarter 2026 Financial Results and Business HighlightsNasdaq
- Compass Pathways Announces Third Quarter 2026 Financial Results and Business HighlightsBusiness Wire
- Monday's ETF Movers: TAN, ARKGNasdaqNXT, ENPH, CMPS, QSI
- 1 Reason Compass Pathways Is Worth a Second Look This MonthNasdaqCMPS, HEI.A
- Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026Business Wire
COMPASS Pathways Plc American Depository Shares peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HROWHarrow Inc. | 30.41 | -5.35% | $1.14B | vs CMPS |
| GPCRStructure Therapeutics Inc. ADR | 16.13 | -5.78% | $1.15B | vs CMPS |
| AAPGAscentage Pharma Group International American Depository Shares | 11.97 | -3.78% | $1.12B | vs CMPS |
| OPKOPKO Health Inc. | 1.57 | -2.48% | $1.17B | vs CMPS |
| KARDKardigan Inc. | 11.54 | -7.83% | $1.08B | vs CMPS |
| GHRSGH Research PLC | 17.53 | -5.55% | $1.20B | vs CMPS |
| AMPHAmphastar Pharmaceuticals Inc. | 28.25 | +0.50% | $1.20B | vs CMPS |
| MLYSMineralys Therapeutics Inc. | 13.66 | -3.53% | $1.21B | vs CMPS |
Indexes, lists and sector
COMPASS Pathways Plc American Depository Shares stock FAQ
What is COMPASS Pathways Plc American Depository Shares's stock price today?
CMPS last traded at $8.05 as of Nov 20, 4:00 PM EST, down 6.94% on the day. Prices are delayed at least 15 minutes.
Who is COMPASS Pathways Plc American Depository Shares's CEO?
Mr. Kabir Kumar Nath M.A., M.B.A. is the chief executive officer of COMPASS Pathways Plc American Depository Shares, which has about 156 employees.
What is the CMPS 52-week high?
The 52-week high for CMPS is $15.87 and the 52-week low is $4.88. The stock is currently 49.3% below its high.